RECALLS AND FIELD CORRECTIONS: DRUGS - CLASS I ___________________________________ PRODUCT Methadone HCI Oral Solution, 20mg, Recall # D-232-2008 CODE VistaPharm Lot # 135100 Whitney Lot # 5364 L RECALLING FIRM/MANUFACTURER Whitney Labs, Ormond Beach, FL, by telephone on March 14, 2008. Firm initiated recall is ongoing. REASON Misbranded; bottles labeled as containing 20mg Methadone HCI actually contains 260 mg Methadone HCI. VOLUME OF PRODUCT IN COMMERCE 143 bottles DISTRIBUTION AL, NC, NH, FL RECALLS AND FIELD CORRECTIONS: DRUGS - CLASS III ___________________________________ PRODUCT Guanfacine Tablets, USP 1 mg, 100 and 500 count bottles, NDC 52152-118-04 , NDC 52152-118-02; 100 count bottles, NDC 0603-3774-21; 100 count bottles, NDC 0904-5579-60, Recall # D-234-2008 CODE Lots: 60366A1 Apr-08 60583A1 Jun-08 60583A2 Jun-08 60746A1 Aug-08 60746A2 Aug-08 60955A1 Nov-08 60955A2 Nov-08 70012A1 Jan-09 70012A2 Jan-09 70230A1 Mar-09 70230A2 Mar-09 70329A1 Apr-09 70499A1 Jun-09 70634A1 Jul-09 70634A2 Jul-09 70943A1 Nov-09 70943A2 Nov-09 80042A1 Jan-10 80106A1 Feb-10 RECALLING FIRM/MANUFACTURER Actavis Totowa LLC, Totowa, NJ, by letters on April 30, 2008. Firm initiated recall is ongoing. REASON Exceeded impurity specification. VOLUME OF PRODUCT IN COMMERCE 18 lots DISTRIBUTION Nationwide ___________________________________ PRODUCT Guanfacine Tablets, USP 2 mg, 100 and 500 count bottles, Rx only, NDC 52152-119-04 - 500 tablets; NDC 52152-119-02 - 100 tablets, Recall # D-235-2008 CODE Lots: 60317A1 Apr-08 60317A2 Apr-08 60509A1 Jun-08 60509A2 Jun-08 60956A1 Nov-08 60956A2 Nov-08 70011A1 Jan-09 70011A2 Jan-09 70491A1 Jun-09 70491A2 Jun-09 70635A1 Jul-09 70635A2 Jul-09 70944A1 Nov-09 70944A2 Nov-09 80101A2 Feb-10 80101A1 Feb 10 RECALLING FIRM/MANUFACTURER Actavis Totowa LLC, Totowa, NJ, by letters on April 30, 2008. Firm initiated recall is ongoing. REASON Exceeded impurity specification. VOLUME OF PRODUCT IN COMMERCE 16 lots DISTRIBUTION Nationwide ___________________________________ PRODUCT Ipratropium Bromide and Albuterol Sulfate Inhalation Solution, 0.5mg/3mg, Sterile Unit Dose Vials, For Inalation Only, packaged as 6 pouches of 5 (3 ml) vials each (30 unit-dose vials) NDC 0093-6723-73 and 12 pouches of 5 (3 ml) vials (60 unit-dose vials) NDC number 0093-6723-74, Recall # D-236-2008 CODE Lot number W21181 exp 9/2009 and Lot number W21501 exp 10/2009 RECALLING FIRM/MANUFACTURER Recalling Firm: Teva Pharmaceuticals USA, North Wales, PA, by letter on May 21, 2008. Manufacturer: IVAX Pharmaceuticals U.K., Ltd. Cheshire, UK. Firm initiated recall is ongoing. REASON Failed pH Specification VOLUME OF PRODUCT IN COMMERCE 2,123,450 vials DISTRIBUTION LA, NC, NJ, NV, OH, and PR Zynchros Pharmacy Services